TIDM0RN3
FORM 8.3 Amendment to Sales
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of
interest and short
positions disclosed, if
different from 1(a):
(c) Name of offeror/offeree TAKEDA PHARMACEUTICAL CO LTD
in relation to whose
relevant securities this form relates:
(d) If an exempt fund manager
connected with an
offeror/offeree, state this
and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 07 January 2019
(f) In addition to the company in 1(c) YES:
above, is the discloser making
disclosures in respect of any SHIRE PLC
other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant Ordinary NPV
security:
Interests Short Positions
Number (%) Number (%)
(1) Relevant
securities
owned
and/or 11,639,618 1.48% 18,916,042 2.38%
controlled:
(2) Cash-settled
derivatives:
8,788,961 1.11% 1,675,035 0.21%
(3) Stock-settled
derivatives
(including
options)
and agreements 514,600 0.06% 514,600 0.06%
to
purchase/sell:
TOTAL: 20,943,179 2.65% 21,105,677 2.66%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors'
and other employee options)
Class of relevant security in relation
to which subscription right exists:
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 19 18.6000 USD
ADR Purchase 47 18.5600 USD
ADR Purchase 100 18.4900 USD
ADR Purchase 100 18.6250 USD
ADR Purchase 300 18.5500 USD
ADR Purchase 1,100 18.5845 USD
ADR Purchase 2,400 18.5725 USD
ADR Purchase 6,100 18.5111 USD
ADR Purchase 6,600 18.5657 USD
ADR Purchase 68,400 18.5630 USD
ADR Purchase 74,900 18.5633 USD
ADR Purchase 170,800 18.5662 USD
ADR Sale 19 18.6000 USD
ADR Sale 47 18.5600 USD
ADR Sale 100 18.6250 USD
ADR Sale 100 18.4750 USD
ADR Sale 100 18.5250 USD
ADR Sale 200 18.5850 USD
ADR Sale 246 18.6100 USD
ADR Sale 300 18.5050 USD
ADR Sale 300 18.5700 USD
ADR Sale 400 18.5175 USD
ADR Sale 600 18.5083 USD
ADR Sale 800 18.5112 USD
ADR Sale 1,200 18.5095 USD
ADR Sale 1,300 18.5115 USD
ADR Sale 1,300 18.5146 USD
ADR Sale 3,900 18.5720 USD
ADR Sale 4,200 18.6650 USD
ADR Sale 4,500 18.5550 USD
ADR Sale 4,703 18.5552 USD
ADR Sale 5,100 18.5452 USD
ADR Sale 7,200 18.5470 USD
ADR Sale 8,298 18.5682 USD
ADR Sale 9,100 18.5728 USD
ADR Sale 11,714 18.5457 USD
ADR Sale 19,645 18.5660 USD
ADR Sale 19,883 18.5673 USD
ADR Sale 39,500 18.5521 USD
ADR Sale 47,748 18.5693 USD
ADR Sale 65,900 18.5621 USD
ADR Sale 77,009 18.5756 USD
Ordinary NPV Purchase 800 3,978.6875 JPY
Ordinary NPV Purchase 1,000 3,951.1000 JPY
Ordinary NPV Purchase 1,000 3,978.4000 JPY
Ordinary NPV Purchase 1,700 3,987.4058 JPY
Ordinary NPV Purchase 1,700 3,990.2764 JPY
Ordinary NPV Purchase 1,900 3,992.5789 JPY
Ordinary NPV Purchase 2,400 3,966.4166 JPY
Ordinary NPV Purchase 3,100 3,991.0000 JPY
Ordinary NPV Purchase 3,100 3,987.1871 JPY
Ordinary NPV Purchase 3,500 3,991.1714 JPY
Ordinary NPV Purchase 4,300 3,977.2790 JPY
Ordinary NPV Purchase 4,500 3,963.4777 JPY
Ordinary NPV Purchase 4,600 3,941.3260 JPY
Ordinary NPV Purchase 4,800 4,035.7500 JPY
Ordinary NPV Purchase 5,800 3,984.0000 JPY
Ordinary NPV Purchase 7,700 3,978.6883 JPY
Ordinary NPV Purchase 8,700 3,970.2701 JPY
Ordinary NPV Purchase 9,700 3,915.8762 JPY
Ordinary NPV Purchase 9,900 3,987.6666 JPY
Ordinary NPV Purchase 11,500 3,986.7834 JPY
Ordinary NPV Purchase 11,900 3,971.6890 JPY
Ordinary NPV Purchase 12,900 3,979.8062 JPY
Ordinary NPV Purchase 13,000 3,975.1538 JPY
Ordinary NPV Purchase 17,600 3,981.8636 JPY
Ordinary NPV Purchase 19,400 3,978.5670 JPY
Ordinary NPV Purchase 30,000 3,981.0266 JPY
Ordinary NPV Purchase 31,200 3,978.2115 JPY
Ordinary NPV Purchase 47,300 3,980.2304 JPY
Ordinary NPV Purchase 98,200 3,990.7841 JPY
Ordinary NPV Purchase 190,000 3,954.4900 JPY
Ordinary NPV Purchase 421,200 3,979.5439 JPY
Ordinary NPV Purchase 456,700 3,980.0102 JPY
Ordinary NPV Purchase 859,100 3,981.3206 JPY
Ordinary NPV Purchase 866,900 3,980.0862 JPY
Ordinary NPV Sale 400 3,966.0000 JPY
Ordinary NPV Sale 400 3,998.7500 JPY
Ordinary NPV Sale 1,000 3,945.8000 JPY
Ordinary NPV Sale 1,000 3,951.1000 JPY
Ordinary NPV Sale 1,000 4,006.9000 JPY
Ordinary NPV Sale 1,600 3,991.6000 JPY
Ordinary NPV Sale 1,700 3,990.2764 JPY
Ordinary NPV Sale 2,000 4,034.6500 JPY
Ordinary NPV Sale 2,400 3,966.4166 JPY
Ordinary NPV Sale 2,800 3,989.5357 JPY
Ordinary NPV Sale 4,100 3,981.4097 JPY
Ordinary NPV Sale 4,300 3,977.2790 JPY
Ordinary NPV Sale 6,700 3,966.3432 JPY
Ordinary NPV Sale 8,400 4,014.0476 JPY
Ordinary NPV Sale 8,700 3,970.2701 JPY
Ordinary NPV Sale 8,700 3,974.0000 JPY
Ordinary NPV Sale 11,500 3,986.7834 JPY
Ordinary NPV Sale 11,700 3,971.4615 JPY
Ordinary NPV Sale 13,000 4,080.0000 JPY
Ordinary NPV Sale 100,000 3,975.4300 JPY
Ordinary NPV Sale 421,200 3,978.9399 JPY
Ordinary NPV Sale 846,100 3,979.8045 JPY
Ordinary NPV Sale 869,300 3,980.0473 JPY
Ordinary NPV Sale 1,033,600 3,978.4521 JPY
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 1,600 4,057.6300 JPY
Ordinary NPV CFD Long 150,000 3,985.9913 JPY
Ordinary NPV SWAP Short 2,800 3,969.6778 JPY
Ordinary NPV CFD Short 8,300 3,993.8209 JPY
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number Exercise price Type Expiry date Option money
relevant descriptione.g. purchasing, of securities per unit e.g. American, paid/
security call selling, to European etc. received
option varying etc. which option per unit
relates
(ii) Exercise
Class of relevant Product Exercising/ Number Exercise price
security description exercised of securities per unit
e.g. call against
option
(d) Other dealings (including subscribing for new
securities)
Class of relevant Nature of dealing Details Price per unit (if
security e.g. subscription, applicable)
conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement,
or any agreement or understanding,
formal or informal, relating to relevant securities
which may be an inducement to
deal or refrain from dealing entered into
by the person making the disclosure and
any party to the offer or any person acting
in concert with a party to the offer:
Irrevocable commitments and letters of intent
should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or
understanding, formal or informal,
between the person making the disclosure
and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any
relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements
or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open YES
Positions) attached?
Date of disclosure: 9 Jan 2019
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION)
POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Identity of the person whose Barclays PLC.
positions/dealings
are being disclosed:
Name of offeror/offeree TAKEDA PHARMACEUTICAL CO LTD
in relation to whose
relevant securities this from relates:
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary Call Purchased 150,000 3889.0000 American 11 Jun 2021
NPV Options
Ordinary Call Written -114,000 4750.0200 European 14 May 2019
NPV Options
Ordinary Call Written -104,700 5065.8300 European 17 Apr 2019
NPV Options
Ordinary Call Written -75,900 4286.5200 European 6 Sep 2019
NPV Options
Ordinary Call Written -70,000 4598.0000 European 14 Jun 2019
NPV Options
Ordinary Put Purchased -150,000 3889.0000 American 11 Jun 2021
NPV Options
Ordinary Put Written 70,000 4598.0000 European 14 Jun 2019
NPV Options
Ordinary Put Written 75,900 4286.5200 European 6 Sep 2019
NPV Options
Ordinary Put Written 104,700 5065.8300 European 17 Apr 2019
NPV Options
Ordinary Put Written 114,000 4750.0200 European 14 May 2019
NPV Options
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of
the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form
(Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be
stated.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190109005528/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
January 09, 2019 09:49 ET (14:49 GMT)
Takeda Pharmaceutical (LSE:0RN3)
Historical Stock Chart
From Apr 2024 to May 2024
Takeda Pharmaceutical (LSE:0RN3)
Historical Stock Chart
From May 2023 to May 2024